| Literature DB >> 27301870 |
Jin-Ju Zhang1,2, Jing-Feng Xu1,3, Yong-Wei Shen3, Shi-Jiao Ma1,3, Ting-Ting Zhang1,3, Qing-Lin Meng1, Wen-Jun Lan1, Chun Zhang1, Xiao-Mei Liu1.
Abstract
Gene doping can be easily concealed since its product is similar to endogenous protein, making its effective detection very challenging. In this study, we selected insulin-like growth factor I (IGF-I) exogenous gene for gene doping detection. First, the synthetic IGF-I gene was subcloned to recombinant adeno-associated virus (rAAV) plasmid to produce recombinant rAAV2/IGF-I-GFP vectors. Second, in an animal model, rAAV2/IGF-I-GFP vectors were injected into the thigh muscle tissue of mice, and then muscle and blood specimens were sampled at different time points for total DNA isolation. Finally, real-time quantitative PCR was employed to detect the exogenous gene doping of IGF-I. In view of the characteristics of endogenous IGF-I gene sequences, a TaqMan probe was designed at the junction of exons 2 and 3 of IGF-I gene to distinguish it from the exogenous IGF-I gene. In addition, an internal reference control plasmid and its probe were used in PCR to rule out false-positive results through comparison of their threshold cycle (Ct) values. Thus, an accurate exogenous IGF-I gene detection approach was developed in this study.Entities:
Keywords: IGF-I; gene doping; gene therapy; internal reference control (IRC); real-time quantitative PCR; recombinant adeno-associated virus (rAAV)
Mesh:
Substances:
Year: 2017 PMID: 27301870 DOI: 10.1002/bab.1518
Source DB: PubMed Journal: Biotechnol Appl Biochem ISSN: 0885-4513 Impact factor: 2.431